Upgrade to SI Premium - Free Trial

RADX (RADX)

4.38 +0.06 (1.39%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/25/26 *Est.)

Latest Headlines

H.C. Wainwright Starts Radiopharm Theranostics (RADX) at Buy June 4, 2026 6:07 AM - StreetInsider Form 6-K Radiopharm Theranostics For: Jun 03 June 3, 2026 8:00 AM - SEC Filing A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology May 14, 2026 9:15 AM - StreetInsider Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Voliotis Dimitris May 6, 2026 9:09 PM - SEC Filing Form 3 Radiopharm Theranostics For: Mar 18 Filed by: HOPPER PAUL May 6, 2026 6:08 AM - SEC Filing Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Laurita Aaron James April 30, 2026 9:52 PM - SEC Filing Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing April 29, 2026 8:35 AM - Globe NewsWire International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026 April 23, 2026 8:35 AM - Globe NewsWire Radiopharm Theranostics Reports Business Update April 23, 2026 7:02 AM - Globe NewsWire Radiopharm presents early trial data for HER2-targeted cancer therapy April 20, 2026 7:00 AM - StreetInsider Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026 April 20, 2026 7:00 AM - Globe NewsWire Radiopharm moves to next dose level in cancer drug trial April 8, 2026 7:01 AM - StreetInsider Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial April 8, 2026 7:00 AM - Globe NewsWire Radiopharm Theranostics partners with Siemens for RAD101 supply April 7, 2026 10:07 AM - StreetInsider Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S. April 7, 2026 10:07 AM - Globe NewsWire Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Donnelly Noel April 1, 2026 9:46 PM - SEC Filing Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Turner Ian Lawrence April 1, 2026 6:09 AM - SEC Filing Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Canevari Riccardo March 31, 2026 6:21 AM - SEC Filing Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Larkin Hester Denise March 31, 2026 6:21 AM - SEC Filing Radiopharm doses first patient in RAD 402 prostate cancer trial March 27, 2026 7:01 AM - StreetInsider Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer March 27, 2026 7:00 AM - Globe NewsWire Radiopharm Theranostics reports 90% success rate in brain imaging trial March 24, 2026 7:00 AM - StreetInsider Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases March 24, 2026 7:00 AM - Globe NewsWire Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Goodwin Bruce Michael March 18, 2026 8:56 AM - SEC Filing Full Article List